XML 34 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other-Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Total
Balances at beginning at Dec. 31, 2017 $ 7 $ 45,702 $ 79,101,824 $ (39,378) $ (61,960,910) $ 17,147,245
Balances at beginning (in shares) at Dec. 31, 2017 6,760 45,701,593        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock in exchange of preferred stock $ (4) $ 4,651 (5,251)     (604)
Issuance of common stock in exchange of preferred stock (in shares) (4,000) 4,651,163        
Stock option expense     770,861     770,861
Issuance of common stock pursuant to exercise of stock options - Cashless   $ 306 (306)    
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)   306,340        
Issuance of common stock pursuant to exercise of stock options - Cash   $ 298 142,329     142,627
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)   297,773        
Preferred stock dividend payable         (82,691) (82,691)
Foreign currency translation gain (loss)       (53,504)   (53,504)
Net Income (Loss)         (2,876,504) (2,876,504)
Balances at ending at Mar. 31, 2018 $ 3 $ 50,957 80,009,457 (92,882) (64,920,105) 15,047,430
Balances at ending (in shares) at Mar. 31, 2018 2,760 50,956,869        
Balances at beginning at Dec. 31, 2017 $ 7 $ 45,702 79,101,824 (39,378) (61,960,910) 17,147,245
Balances at beginning (in shares) at Dec. 31, 2017 6,760 45,701,593        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Preferred stock dividend payable           (169,494)
Net Income (Loss)           (10,356,876)
Balances at ending at Sep. 30, 2018 $ 3 $ 51,125 82,659,486 6,752 (71,704,224) 11,013,142
Balances at ending (in shares) at Sep. 30, 2018 2,760 51,124,946        
Balances at beginning at Mar. 31, 2018 $ 3 $ 50,957 80,009,457 (92,882) (64,920,105) 15,047,430
Balances at beginning (in shares) at Mar. 31, 2018 2,760 50,956,869        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option expense     1,179,764     1,179,764
Issuance of common stock pursuant to exercise of stock options - Cash   $ 106 37,575     37,681
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)   106,282        
Preferred stock dividend payable         (43,164) (43,164)
Foreign currency translation gain (loss)       33,685   33,685
Net Income (Loss)         (3,348,658) (3,348,658)
Balances at ending at Jun. 30, 2018 $ 3 $ 51,063 81,226,796 (59,197) (68,311,927) 12,906,738
Balances at ending (in shares) at Jun. 30, 2018 2,760 51,063,151        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option expense     1,153,152     1,153,152
Issuance of common stock pursuant to exercise of stock options - Cashless   $ 2 (2)      
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)   1,795        
Preferred stock dividend payable         (43,639) (43,639)
Foreign currency translation gain (loss)       65,949   65,949
Issuance of common stock in exchange of service   $ 60 279,540     279,600
Issuance of common stock in exchange of service (in shares)   60,000        
Net Income (Loss)         (3,348,658) (4,131,714)
Balances at ending at Sep. 30, 2018 $ 3 $ 51,125 82,659,486 6,752 (71,704,224) 11,013,142
Balances at ending (in shares) at Sep. 30, 2018 2,760 51,124,946        
Balances at beginning at Dec. 31, 2018 $ 57,003 85,153,667 (26,997) (73,380,691) 11,802,982 [1]
Balances at beginning (in shares) at Dec. 31, 2018 57,002,508        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option expense     1,358,503     1,358,503
Issuance of common stock pursuant to exercise of stock options - Cashless   $ 115 (115)    
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)   115,107        
Issuance of common stock pursuant to exercise of stock options - Cash   $ 80 24,680     24,760
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)   80,750        
Beneficial Conversion Feature on Convertible Instruments     166,667     166,667
Foreign currency translation gain (loss)       260,665   260,665
Net Income (Loss)         11,656,594 11,656,594
Balances at ending at Mar. 31, 2019 $ 57,198 86,703,402 233,668 (61,724,097) 25,270,171
Balances at ending (in shares) at Mar. 31, 2019 57,198,365        
Balances at beginning at Dec. 31, 2018 $ 57,003 85,153,667 (26,997) (73,380,691) 11,802,982 [1]
Balances at beginning (in shares) at Dec. 31, 2018 57,002,508        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income (Loss)           11,144,342
Balances at ending at Sep. 30, 2019 $ 68,876 126,075,609 (571,120) (62,236,350) 63,337,015
Balances at ending (in shares) at Sep. 30, 2019 68,875,257        
Balances at beginning at Mar. 31, 2019 $ 57,198 86,703,402 233,668 (61,724,097) 25,270,171
Balances at beginning (in shares) at Mar. 31, 2019 57,198,365        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option expense     1,095,792     1,095,792
Issuance of common stock pursuant to exercise of stock options - Cashless   $ 80 (80)    
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)   79,488        
Issuance of common stock pursuant to exercise of stock options - Cash   $ 93 122,574     122,667
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)   93,334        
Foreign currency translation gain (loss)       (256,974)   (256,974)
Net Income (Loss)         (1,473,295) (1,473,295)
Balances at ending at Jun. 30, 2019 $ 57,371 87,921,688 (23,306) (63,197,392) 24,758,361
Balances at ending (in shares) at Jun. 30, 2019 57,371,187        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option expense     900,000     900,000
Issuance of common stock-Capital Raise   $ 7,986 26,947,451     26,955,437
Issuance of common stock-Capital Raise (in shares)   7,986,110        
Issuance of common stock-Notes Payable Conversion   $ 3,197 10,230,136     10,233,333
Issuance of common stock-Notes Payable Conversion (in shares)   3,196,460        
Issuance of common stock pursuant to exercise of stock options - Cashless   $ 250 (250)      
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)   250,000        
Issuance of common stock pursuant to exercise of stock options - Cash   $ 72 76,584     76,656
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)   71,500        
Foreign currency translation gain (loss)       (547,814)   (547,814)
Net Income (Loss)         961,042 961,042
Balances at ending at Sep. 30, 2019 $ 68,876 $ 126,075,609 $ (571,120) $ (62,236,350) $ 63,337,015
Balances at ending (in shares) at Sep. 30, 2019 68,875,257        
[1] Derived from Audited Financial Statements